# US 2026/0256837 A1 · Palatability-Enhanced Activated Charcoal Systems Enabling Voluntary Ingestion for Toxin Removal in Animals

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0256837 A1
- Document ID: US20260256837A1
- Status: Published application
- Kind: A1
- Application number: 19/651,739
- Filed: 2026-04-19
- Published: 2026-09-03
- Earliest claimed: 2025-10-24
- Assignees: Pet Vet Products, LLC
- Applicants: Pet Vet Products, LLC
- Inventors: Leah Hill
- Web page: https://patentgrep.com/patent/US20260256837A1

## CPC

- A61K 33/44: Elemental carbon, e.g. charcoal, carbon black
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/0065: {Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus}
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Veterinary compositions and methods employing activated charcoal optimized for adsorption and removal of toxins from animals are disclosed. Formulations include oral suspensions, pastes, boluses, feed additives, and enteral-compatible suspensions with defined charcoal physical characteristics and optional adjuvants to enhance palatability, adsorption specificity, and safety. Species-specific dosing regimens and administration kits for emergency veterinary toxin management are provided.

## Claims

### Claim 1

A veterinary composition for reducing systemic absorption of an ingested toxin in an animal, comprising:
(a) activated charcoal; and
(b) a palatability-enhancing system comprising one or more flavoring agents, carriers, coatings, or encapsulating components, wherein the palatability-enhancing system is configured to maintain detectable flavor perception in the presence of the activated charcoal despite adsorptive properties of the activated charcoal and to enable voluntary oral ingestion by the animal without restraint or forced administration.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the palatability-enhancing system maintains detectable flavor perception after contact with activated charcoal.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the palatability-enhancing system comprises a flavor component that is physically or chemically protected from adsorption by the activated charcoal.

### Claim 4 (depends on 2)

The composition of claim 2, wherein the palatability-enhancing system maintains flavor perception after mixing with activated charcoal in vivo.

### Claim 5 (depends on 3)

The composition of claim 3, wherein the flavor component is encapsulated, lipid-bound, polymer-bound, or coated.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the composition is voluntarily consumed without syringe feeding, restraint, or gastric intubation.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the palatability-enhancing system improves voluntary consumption relative to unflavored activated charcoal.

### Claim 8 (depends on 1)

The composition of claim 1, wherein the composition is configured for administration in a non-clinical environment following toxin ingestion.

### Claim 9

A veterinary composition for reducing systemic absorption of an ingested toxin in an animal, comprising activated charcoal having a specific surface area of 500 to 2500 m2/g and a particle size distribution of 10 to 500 micrometers, dispersed in a pharmaceutically acceptable oral carrier.

### Claim 10 (depends on 1)

The composition of claim 1 formulated as an oral paste or gel comprising a humectant and a flavoring agent.

### Claim 11 (depends on 1)

The composition of claim 1 formulated as a bolus comprising aggregated activated charcoal particles having a diameter of 0.5 to 5 mm and a taste-masking coating.

### Claim 12 (depends on 1)

The composition of claim 1 further comprising an adsorbent-enhancing adjuvant selected from ionic surfactants and polymeric affinity modifiers configured to increase adsorption of lipophilic toxins.

### Claim 13 (depends on 1)

A method of treating an animal exposed to a toxin, comprising administering to the animal an effective amount of the composition of claim 1 within 4 hours of exposure.

### Claim 14 (depends on 13)

The method of claim 13, wherein the effective amount is 0.25 to 4 g/kg body weight for dogs and cats.

### Claim 15 (depends on 13)

The method of claim 13, further comprising co-administering a veterinarian-selected cathartic or antidote, and repeating administration of the composition every 4 to 6 hours based on clinical judgment.

### Claim 16 (depends on 13)

The method of claim 13, wherein the effective amount is 0.25 to 1 g/kg body weight.

### Claim 17 (depends on 1)

A kit for veterinary toxin management comprising: a supply of the composition of claim 1 in pre-measured single-dose units; instructions identifying species-specific dosing; and an administration implement suitable for enteral dosing.

### Claim 18

A method of reducing systemic absorption of an ingested toxin in an animal, comprising administering activated charcoal having a specific surface area of 500 to 2500 m2/g and a particle size distribution of 10 to 500 micrometers.

### Claim 19 (depends on 1)

The composition of claim 1, wherein the palatability-enhancing system is resistant to adsorption by the activated charcoal.

### Claim 20 (depends on 13)

The method of claim 13, wherein administration occurs in a non-clinical setting within 4 hours of suspected ingestion.

### Claim 21 (depends on 1)

A veterinary toxin management kit comprising:
(a) the composition of claim 1 in pre-measured doses;
(b) instructions for species-specific dosing; and
(c) an administration implement.

### Claim 22 (depends on 1)

The composition of claim 1, wherein the composition is formulated as a gel, paste, liquid, suspension, bolus, or edible treat.

### Claim 23 (depends on 1)

The composition of claim 1, wherein the composition is packaged in a weight-based dosing format for consumer use.

### Claim 24 (depends on 1)

The composition of claim 1, wherein the animal is selected from a companion animal, livestock animal, or equine.
